Inhibitor Therapeutics, Inc. (INTI): Shareholders' Equity
-$1.29M
As of 2025-12-31
-$2.56M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.29M | n/m | 2026-03-26, Balance as of period end |
| 2024-12-31 | $1.99M | -62.4% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $5.28M | -36.3% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $8.30M | n/m | 2024-03-29, Balance as of period end |
| 2021-12-31 | -$3.62M | n/m | 2023-03-31, Balance as of period end |
| 2020-12-31 | -$3.36M | n/m | 2022-03-30, Balance as of period end |
| 2019-12-31 | -$2.53M | n/m | 2021-03-26, Balance as of period end |
| 2018-12-31 | $32.4K | -80.6% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $166.6K | -97.6% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $7.03M | n/m | 2018-02-16, Balance as of period end |
| 2015-12-31 | $424.0K | +583.0% | 2017-02-17, Balance as of period end |
| 2014-12-31 | $62.1K | n/m | 2016-02-01, Balance as of period end |
| 2013-12-31 | -$765.8K | n/m | 2015-02-13, Balance as of period end |
| 2012-12-31 | -$132.8K | n/a | 2014-04-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Inhibitor Therapeutics, Inc. (INTI) | 2025-12-31 | -$1.29M | n/m |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$2.49M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $1.92M | -39.0% |
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | -$1.27M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.14M | -57.0% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$17.51M | n/m |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $1.83M | -34.5% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.15M | +4.4% |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | $1.08M | -92.0% |
Compare INTI, VCNX, LIPO, ARTL side by side · Screen every company in Pharmaceutical Preparations ↗